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Copy number variants (CNVs) are an important component of genomic variation in humans and other mammals. Similar de novo dele-
tions and duplications, or copy number changes (CNCs), are now known to be amajor cause of genetic and developmental disorders and
to arise somatically inmany cancers. Amajormechanism leading to both CNVs and disease-associated CNCs is meiotic unequal crossing
over, or nonallelic homologous recombination (NAHR), mediated by ﬂanking repeated sequences or segmental duplications. Others
appear to involve nonhomologous end joining (NHEJ) or aberrant replication suggesting a mitotic cell origin. Here we show that aphi-
dicolin-induced replication stress in normal human cells leads to a high frequency of CNCs of tens to thousands of kilobases across the
human genome that closely resemble CNVs and disease-associated CNCs. Most deletion and duplication breakpoint junctions were
characterized by short (<6 bp) microhomologies, consistent with the hypothesis that these rearrangements were formed by NHEJ or
a replication-coupled process, such as template switching. This is a previously unrecognized consequence of replication stress and
suggests that replication fork stalling and subsequent error-prone repair are important mechanisms in the formation of CNVs and path-
ogenic CNCs in humans.Introduction
In recent years, copy number variants (CNVs) involving
tens to thousands of kilobases of DNA have been found
to be widely distributed throughout the human
genome.1–4 They are an important component of genomic
variation and are likely to play an integral role in pheno-
typic diversity.5 Most have been discovered through
screening the human genome with high-resolution
methods such as aCGH and SNP analysis or with
sequencing approaches. Recent studies have shown that
more than 1300 CNVs exist as heterozygous or homozy-
gous deletions or duplications among healthy individ-
uals,2,6–8 and this number will undoubtedly increase as
even higher resolution data become available. Common
CNVs are typically heritable polymorphisms and are
enriched in areas of segmental duplications.9 Some CNVs
show high levels of linkage disequilibrium with ﬂanking
SNP markers, suggesting that they arose from single events
in evolution, whereas others appear to have arisen on
multiple chromosomes.9
Similar de novo submicroscopic deletions and duplica-
tions, here referred to as copy number changes (CNCs) to
distinguish them from population variants, are now
known to be a major cause of genetic and developmental
disorders, including mental retardation, autism, epilepsy,
psychiatric disorders, skeletal defects, and others (reviewed
in 10). Numerous studies of large cohorts of individuals
with mental retardation and developmental disorders
have found submicroscopic CNCs in 5%–17% of affected
individuals.10 Most of these CNCs arise sporadically, varyThe Amin size, and can occur throughout the genome. Similar
CNCs are also being found at high frequencies in many
tumors where their role in initiation or progression is
only now being studied.11–13
The mechanisms giving rise to CNVs and pathogenic
CNCs are not fully understood. The sequences at break-
point junctions have led to inferred mechanisms for
some CNVs and CNCs. Meiotic unequal crossing over, or
nonallelic homologous recombination (NAHR), mediated
by ﬂanking repeated sequences or segmental duplications
is an important mechanism leading to a number of normal
CNVs and most recurrent disease-associated CNCs, such as
those recently identiﬁed at 16p11.2 and 17q21.3 in autism
and mental retardation, respectively.14,15 This is a classic
mechanism ﬁrst implicated in the formation of larger mi-
crodeletions and duplications associated with human
syndromes, such as Prader-Willi (PWS [MIM 176270])
and DiGeorge (DGS [MIM 188400]) syndromes (reviewed
in 16).
Although recurrent CNCs are clearly associated with
unequal meiotic recombination events, less is known
about the mechanisms underlying the formation of
normal CNVs and sporadic, nonrecurrent CNCs, which
account for the majority of disease-associated copy
number alterations in humans. Moreover, little is under-
stood regarding their origin in mitotic cells, as would be
the case for those that arise during tumorigenesis and in
human somatic tissues. The limited available exact break-
point data suggest that many arise by mechanisms other
than meiotic NAHR. Recent reports have described break-
point junction sequences at a number of normal1Department of Human Genetics, University of Michigan, Ann Arbor, MI 48109, USA; 2Department of Human Genetics, Emory University, Atlanta, GA
30322, USA
*Correspondence: glover@umich.edu
DOI 10.1016/j.ajhg.2009.01.024. ª2009 by The American Society of Human Genetics. All rights reserved.erican Journal of Human Genetics 84, 339–350, March 13, 2009 339
CNVs.17–19 These data demonstrate that the majority of
human CNVs greater than 10 kb in size show short
sequence microhomology at breakpoint junctions and
appear to be generated by nonhomologous DNA repair
mechanisms that could include nonhomologus end
joining (NHEJ), alternative or microhomology-mediated
end joining (MMEJ), or long-range template switching,
with the others formed by NAHR or retrotransposition
events. Fewer data are available on the breakpoint
sequences at nonrecurrent, disease-associated CNCs,
including those found in cancer cells, but most are also
consistent with mechanisms involving nonhomologous
repair or aberrant replication.20–24 Because chromosomes
are replicated prior to meiosis, and NHEJ appears to be
downregulated during mammalian meiosis,25 these data
suggest a mitotic rather than meiotic cell origin for many
CNVs and CNCs associated with genetic disease and
certainly those arising in cancer cells.
The initial events (e.g., DNA damage or replication
errors) that lead to copy number alterations in mitotic cells
are poorly understood.We have previously reported that in
human-mouse somatic cell hybrids containing human
chromosome 3, aphidicolin (APH)-induced replication
stress leads to a remarkably high frequency of submicro-
scopic deletions, or CNCs, at the common chromosome
fragile site FRA3B. These CNCs closely match the over-
whelming majority of chromosome rearrangements asso-
ciated with this fragile site and the associated FHIT gene
(MIM 601153) in cancer cells.26 The sequences at four
breakpoint junctions showed short microhomology or
insertions suggestive of nonhomologous repair mecha-
nisms in their formation. It was immediately apparent
that these CNCs at FRA3B directly resemble normal
CNVs and disease-associated CNCs in the human genome.
In this current study, we have expanded our examination
of APH-induced replication stress to include the entire
genome of normal human cells. We found that APH
induces a high frequency of CNCs, both submicroscopic
deletions and duplications, distributed across the human
genome with breakpoint junction sequences consistent
with NHEJ mechanisms or a form of template switching.
These results closely match those found for many normal
human CNVs and nonrecurrent CNCs associated with
genetic disease and found in cancer cells.
Material and Methods
Generation of Normal Human Fibroblast Clones
Containing CNCs
The normal, unimmortalized human ﬁbroblast line HGMDFN090
was obtained from the Progeria Research Foundation (Peabody,
MA). Passage 2 HGMDFN090 was grown in DMEM media supple-
mented with 15% FBS. To create replication stress-induced CNCs,
cells were treated with 0.3 mM APH for 72 hr, followed by a 24 hr
recovery period. After treatment, cells were plated at a density of
100–500 cells per 100mm culture dish. After 7–10 days, individual
clones were isolated from these plates with cloning rings. Four340 The American Journal of Human Genetics 84, 339–350, March 1separate culture ﬂasks were treated with APH in each of two exper-
iments to ensure that any recurrent CNCs did not arise from the
same original cell.
aCGH
Whole-genome arrays containing 385,000 (385K) or 2.1 million
(2.1M) unique sequence oligonucleotides were obtained from
Nimblegen Systems. Clones A1B1, A1B4, A1E5, A2A1, A2B2,
A3E1, A5E1, A6A1, A6E2, A7E2, N1A5, N1B2, N2A2, N2A3, N3A3,
N4B2, N5B1, N7B1, and N8B1 were analyzed on 385K arrays.
Clones A1A1, A2C1, A3A2, A4A1, N2B3, and N4A4 were analyzed
on 2.1M arrays. Arrays were prepared according to the manufac-
turer’s protocol. Arrays were scanned on an Axon 4000B scanner
(Molecular Devices) with GenePIx software at 532 and 635 wave-
lengths. Data extraction, normalization, and visualization were
achieved with manufacturer-provided software (NimbleScan and
Signal-Map). Arrays were analyzed for copy number differences
with SegMNT, part of Nimblegen’s NimbleScan software package.
Copy number changes detected by each software package were
manually curated to include only variants with conservative
average log2 ratios of more than 0.20 or less than 0.23. All
detected CNCs were veriﬁed via a second technique.
Validation of CNCs
CNCs identiﬁed by aCGH were veriﬁed with SNPs. Parent cell line
HGMDFN090 was genotyped with an Affymetrix Genome-Wide
Human SNP Array 6.0, with >906,000 SNPs at an average density
of 1 SNP every 3.0 kb. Chips were processed according tomanufac-
turer’s instructions. Genotypes were determined with Birdseed
version 2.0. SNPs mapping to CNCs that were found to be poly-
morphic in the parent HGMDFN090 cell line were PCR ampliﬁed
and sequenced in the derivative clones. Loss of one allele
conﬁrmed the presence of a deletion in the region, whereas a rela-
tive increase in one allele conﬁrmed the presence of a duplication.
Primers were generated based on sequence from National Center
for Biotechnology Information Build 36.1/hg18. PCR reactions
were carried out in 50 ml containing 10 mM Tris-HCl, 50 mM
KCl, 1.5 mM MgCl2, 200 mM deoxynucleotide triphosphates,
1.25 units of Taq polymerase, 0.2 mM ﬁnal concentration of each
primer, and 100 ng of DNA. PCR conditions consisted of an initial
denaturation at 94C for 3 min, followed by 30 cycles of denatur-
ation at 94C for 45 s, annealing at an optimized temperature
between 58C and 63C for 45 s, and an extension at 65C for
45 s, with a ﬁnal extension at 72C for 5 min.
Sequence Analysis
The sequenced deletion and duplication breakpoints were sub-
jected to a number of computational analysis tools. Emboss was
used to calculate the amount of sequence identity between prox-
imal and distal breakpoint regions. RepeatMasker was used to
assess the interspersed repeat element content of each breakpoint.
Tandem repeats within the breakpoint regions were detected with
Mreps. High DNA ﬂexibility peaks within the breakpoint regions
were detected with Twistﬂex. Mfold was used to predict secondary
structures within 30 bp of sequence centered on the breakpoints.
DNA Pattern Find was used to detect sequence motifs reportedly
enriched at deletion breakpoints.27 Segmental duplications within
each CNC were detected with UCSC Genome Browser.
Statistical Methods
Fisher’s two-sided exact test was used for analysis of differences in
the frequency of CNC formation.3, 2009
Table 1. Non-FRA3B CNCs Detected in APH-Treated Chr. 3 Hybrid Clones
Clone Location Del/Dup Span Size (kb) Number of Genes Genes Overlapping CNVs and CNCsa
6-30 3q26.31 Del 174,952,500–175,022,500 70.0 1 NLGN1 DGV
p-851 3q12.1-q13.1 Dup 101,297,500–106,817,500 5520.0 24 ALCAM, RPL24, others DGV, D, R
p-851 3p14.2 Del 61,532,500–61,562,500 30.0 1 PTPRG DGV, D
p-43 3p24.3 Del 17,944,661–18,106,323 161.7 0 - D
p-43 3q13.31 Del 115,952,500–116,027,500 75.0 1 ZBTB20 DGV, D
p-43 3p12.3 Del 76,487,500–76,762,500 275.0 0 - D, R
3-16 3q29 Dup 199,347,500–199,391,229 43.7 0 - R
3-16 3q26.31 Del 175,042,500–175,117,500 75.0 1 NLGN1 0
3-16 3q24 Dup 149,322,508–149,331,933 9.4 0 - D
3-16 3p25 Dup 13,719,490–13,733,238 13.7 0 - DGV, D
a CNVs and CNCs found in the database of genomic variants (DGV), DECIPHER (D), and RedonCNV2 in Ensembl (R).Results
Aphidicolin Induces Submicroscopic Copy Number
Changes across the Normal Human Genome
We previously reported that submicroscopic FHIT/FRA3B
deletions spanning hundreds of kilobases (kb) were
induced at a high frequency in mouse-human chromo-
some 3 somatic cell hybrid cells treated with low-dose
APH.26 Four clonal cell populations with FRA3B deletions
derived from that study were further analyzed by high-
density aCGH for CNCs on chromosome 3. In addition
to the previously reported CNCs in FRA3B, these four cell
clones contained from one to four (mean ¼ 2.5) CNCs
per clone elsewhere on chromosome 3 and not at fragile
sites (Table 1). These ten CNCs consisted of six deletions
and four duplications ranging in size from 9 kb to 5.5 Mb,
with a mean size of 627 kb and a median size of 73 kb. All
breakpoints and locations were unique, with the exception
of two independent overlapping deletions within the
NLGN1 locus (MIM 600568) at 3q26.31.
These ﬁndings suggested that similar events would be
seen across the human genome with APH-induced replica-
tion stress. To test this hypothesis, normal, unimmortal-
ized human ﬁbroblasts were cultured in the presence of
0.3 mM APH for 72 hr, followed by a day of recovery. Indi-
vidual cell clones were isolated and grown for analysis by
whole-genome aCGH with either 385K or 2.1M feature
oligonucleotide arrays. DNA from the original untreated
cell population was used as reference; thus, pre-existing
CNVs in the cell line would not be detected. Fourteen inde-
pendent APH-treated clones and 11 untreated control
clones from two independent experiments were analyzed.
Given the probe density of these arrays and the criteria for
identifying a CNC, CNCs of ~20 kb or larger could be iden-
tiﬁed. Eight out of 14 (57%) APH-treated clones contained
one or more CNCs, whereas only 1/11 (9.1%) untreated
controls had any CNCs (p ¼ 0.017) (Figures 1 and 2A). A
total of 31 CNCs (21 deletions, 10 duplications) were
observed in the APH-treated clones, for a mean of 2.21
CNCs/clone (Table 2). Only two CNCs, both deletions,
were found in a single untreated control clone, an average
of only 0.18 CNCs/clone (Figures 2B and 2C). All CNCs de-The Amertected by aCGH were veriﬁed by either SNP genotyping or
qrtPCR.
The size of the APH-induced CNCs varied widely. On
average, deletions were smaller than duplications, ranging
from 25 kb to 1350 kb with a mean size of 415 kb and
a median size of 244 kb. Duplications ranged from
143 kb to 2880 kb, with a mean size of 1009 kb and
a median size of 648 kb. In addition, one clone had
a very large duplication of more than 32 Mb.
The genomic positions of the APH-induced CNCs in
human ﬁbroblasts are illustrated in Figure 3. There were
three regions of the genome that contained overlapping
CNCs in more than one clone: 3q13.31 (two deletions),
13q31.3 (two deletions), and 15q22.2 (one deletion and
one duplication). Also, when combining data from the
hybrid and ﬁbroblast clones, three clones had nonoverlap-
ping deletions at 3q26.3 and two clones had nonoverlap-
ping CNCs at 18p11.2 (one deletion and one duplication)
(Figure 4A).
Most of the CNCs (25/31; 81%) were found in regions
containing known genes, which is perhaps unsurprising
given their size (Table 2). Several genes known to be
deleted in cancer were found to be deleted in some of the
CNCs, such as CDH13 (MIM 601364).28,29 In addition,
most of the APH-induced CNCs contained or overlapped
with normal CNVs or disease-associated CNCs reported
in the database of genomic variants (25/31; 81%), Redon
CNVs (8/31; 26%),2 or DECIPHER (20/31; 65%) (Table 2).
Although the breakpoints of coincidental CNCs and
CNVs apparently differ, most of the normal CNVs and
disease-associated CNCs were deﬁned with lower-resolu-
tion arrays, resulting in poorly deﬁned boundaries and
the inability to precisely compare breakpoints.
There was no clear association of APH-induced CNCs in
normal ﬁbroblasts with the location of common fragile
sites. None of the CNCs mapped to the two most
frequently broken fragile sites, FRA3B or FRA16D. Only
10/31 CNCs (32%) mapped to chromosome bands that
also contain fragile sites. The 7q32 deletion in clone
A4A1 overlapped with the well-characterized associated
FRA7H fragile site (Figure 4B). In some cases, CNCs map-
ped to chromosome bands containingmapped fragile sites,ican Journal of Human Genetics 84, 339–350, March 13, 2009 341
such as FRA16D, but upon closer evaluation, it was found
that the CNCs and fragile sites did not overlap (Figure 4B).
The other CNC locations corresponded to ‘‘lesser’’ fragile
sites whose boundaries have not been precisely mapped,
such as FRA1I and FRA10E. The imprecise mapping infor-
mation for these fragile sites leaves open the possibility
that the CNCs in these bands do not actually overlap
with the fragile site.
Sequences at CNC Breakpoint Junctions
In most cases, the high-resolution mapping data generated
by aCGH allowed us to deﬁne the CNC breakpoints to
within 10–20 kb. However, we could not map one or
both breakpoint regions with sufﬁcient resolution to allow
this approach in 11/31 CNCs. Pairs of PCR primers were
generated from 16 sets of deletion breakpoints, with the342 The American Journal of Human Genetics 84, 339–350, March 1Figure 1. Examples of APH-Induced CNCs Detected by
aCGH
Representative data illustrating (A) a deletion at 15q22, (B)
a duplication at 10q25, and (C) a tandem deletion and duplica-
tion at Xq21.
forward primer mapping within the left breakpoint
region and the reverse primer mapping within the right
breakpoint region. Because the tens to thousands of
kilobases of intervening sequence are absent from the
deleted chromosome, a PCR product was generated
that crossed the left and right breakpoint boundaries
(Figure 5A). Breakpoint junctions from six deletions in
the APH-treated human ﬁbroblast clones and three
deletions from the human chromosome 3 hybrid
clones were sequenced with this approach. All nine
deletion breakpoint sequences are presented in Table
3. Seven of these sequences were characterized by small
stretches (1–6 bp) of microhomology between the prox-
imal and distal breakpoints. One sequence had no
homology between the proximal and distal break-
points, and one sequence (A3A2, 18p11.23) had a 6 bp
insertion at the breakpoint.
PCR primers were also designed within each break-
point region from four duplications, pointing outward
from the duplication. PCR products from duplications
were generated only when the genomic rearrangement
positioned the primer pair into the correct orientation
(Figure 5B). We successfully sequenced the breakpoints
from two APH-induced duplications (Table 4). Both of
these duplications were positioned in a direct, head-
to-tail orientation. One of these breakpoints was
characterized by 4 bp of microhomology between the
proximal and distal breakpoints. The other sequence
contained a 5 bp insertion at the breakpoint.
We were unsuccessful in generating breakpoint junc-
tion PCR fragments with this approach for seven tar-
geted deletion breakpoints. In three cases, the CNCs
were found to be complex, interrupted by short
stretches of undeleted DNA, as veriﬁed by SNP analysis
with informative SNPs in regions suggested from the
aCGH data to be present in two copies. These regions
were represented by only a few oligonucleotides on the
385K whole-genome arrays and discernable only from
the raw numerical data. In addition, a deletion and dupli-
cation at Xq21.33 in ﬁbroblast clone A5E1 were immedi-
ately adjacent to each other (Figure 1), suggesting a single
event. The high oligonucleotide density of the chr. 3 arrays
used for chr. 3 hybrid CNCs revealed a very complex dele-
tion at 3q26.31 in the NLGN1 locus, as illustrated in
Figure 6. This deletion is characterized by at least ﬁve
distinct interstitial deletions. In addition to the three
conﬁrmed deletions, several other CNCs appear to be
complex based on the aCGH data. In total, interrupted
CNCs were observed in 1/6 chr. 3 hybrid deletions (17%),3, 2009
6/21 ﬁbroblast deletions (29%), and 1/10 ﬁbroblast dupli-
cations (10%).
Analysis of Cloned CNC Breakpoint Sequences
The sequenced deletion and duplication breakpoints were
subjected to a number of computational analysis tools to
identify any features that they might have in common
and that might suggest a cellular DNA repair mechanism
by which they were formed. A total of 4 kb of sequence
Figure 2. APH-Induced Replication Stress Creates Submicro-
scopic CNCs in Normal Human Fibroblasts
(A) Percent of untreated (n¼ 11) and APH-treated (n¼ 14) clones
containing one or more CNCs.
(B) Average number of CNCs per clone in untreated and APH-
treated clones.
(C) Mean number of deletions (gray bars) and duplications (white
bars) in untreated and APH-treated clones.
Error bars indicate standard error.The Amercentered on each breakpoint was analyzed. Emboss was
used to calculate the amount of sequence identity between
proximal and distal breakpoint regions. No difference was
found in the overall sequence identity between proximal
and distal breakpoints from deletions or duplications,
which had a mean of 45.6% identity, and randomly
selected control sequences, which were 45.7% identical.
No extended stretches of sequence identity that would
suggest homology-mediated repair were found in any of
the breakpoint regions. The sequences were 31%–52%
GC, with a mean GC content of 40%. In addition, each
pair of breakpoints had similar GC content, with a mean
difference in GC content between proximal and distal
breakpoints of 3% or less. Randomly chosen control
sequences with similar distance between sequences were
found to have the same similarity in GC content.
With RepeatMasker, we found that there was little simi-
larity in the interspersed repeat element content of each
breakpoint, which ranged from as low as 7.2% to 100%.
Five of the 11 clones had LINE element sequences within
the 4 kb region, but Alu and LTR sequences were each
found at only two breakpoints.
Tandem repeats within these 4 kb regions were detected
with Mreps. A number of tandem repeats, such as (A)11-30,
(AT)6, (GT)15, (CT)5-17, and (GGGGGGT)2, were found, but
there was no pattern in sequence or position relative to the
breakpoint. Also, the number and positions of tandem
repeats in control sequences was similar to those seen in
breakpoint regions.
The Twistﬂex programwas used to detect regions of high
DNA ﬂexibility, as measured by variation in twist angle
between base pairs, within these 4 kb breakpoint regions.
A high concentration of ﬂexibility peaks has been associ-
ated with breakage at common fragile sites.30–32 Very few
ﬂexibility peaks were found in the breakpoint regions.
One 4 kb breakpoint region had a single peak and a second
breakpoint had two peaks. The remaining breakpoint
regions contained no ﬂexibility peaks.
Mfold was used to predict secondary structures within
30 bp of sequence centered on the breakpoints. No
secondary structures were predicted at any of the break-
points. Similarly, analysis with Palindrome detected only
three short 10–13 bp palindromic sequences in three
clones.
DNA Pattern Find was used to detect sequence motifs
reportedly enriched at deletion breakpoints.27 Some
motifs, such as alternating purine-pyrimidine tracts or
polymerase stall sites, were found at nearly all of the break-
points. However, all motifs were found at the same
frequencies in two different sets of control sequences.
Given that enrichment for human CNVs has been found
at segmental duplications,18 we analyzed the breakpoints
from each CNC plus 10 kb of ﬂanking sequence on either
side for segmental duplications with UCSC Genome
Browser. Only 2/11 CNCs, both deletions, contained
segmental duplications. In both cases, these few duplicated
sequences were found in proximity to one another withinican Journal of Human Genetics 84, 339–350, March 13, 2009 343
Table 2. CNCs Detected in APH-Treated Human Fibroblast Clones
Clone Location Del/Dup Span Size (kb)
Number
of Genes Genes Overlapping CNVs and CNCsa
A1A1 13q31.3 Del 93,393,314–93,545,246 151.9 1 GPC6 D
A1B1 7q11.22 Del 69,406,264–69,512,502 106.2 1 AUTS2 D
A1B1 10q21.1 Del 53,518,890–53,637,716 118.8 1 PRKG1 DGV
A1B1 17p13.1 Del 9,762,528–10,018,823 256.3 1 GAS7 DGV
A1E5 2q21 Dup 132,102,000–132,750,000 648.0 1 MGC50273 DGV, D, R
A1E5 15q11.1 Dup 18,258,000–19,386,000 1128.0 1 POTE15 DGV, D, R
A1E5 15q22.2 Dup 57,762,582–58,700,040 924.9 5 BNIP2, ANXA2, others DGV, D
A2A1 10q11.23-q21.1 Del 52,918,772–54,125,252 1206.5 3 PRKG1, CSTF2T, DKK1 DGV
A2B2 16q23.3 Del 82,012,578–82,256,444 243.9 1 CDH13 DGV, D
A3A2 3q13.31 Del 117,988,930–118,751,077 762.1 0 - DGV, D
A3A2 7q11.21 Del 61,379,057–61,440,507 61.5 0 - -
A3A2 9q34.11 Dup 130,303,992–130,698,757 394.8 10 GLE1, SET, others DGV
A3A2 10q25.2 Dup 111,819,613–114,254,912 2435.3 13 ADD3, SMC3, others DGV
A3A2 11p15.4 Del 6,476,848–6,562,692 85.8 1 DNHD1 D
A3A2 15q23 Del 69,469,613–69,494,713 25.1 1 THSD4 DGV
A3A2 18p11.23 Del 7,635,347–7,859,715 224.4 1 PTPRM DGV, D
A4A1 2q23.1 Del 148,836,637–148,895,094 58.5 0 - DGV, D
A4A1 3q26.3 Del 175,261,023–176,266,418 1005.4 2 NLGN1, NAALADL DGV
A4A1 5q21.3 Dup 107,139,095–107,360,201 221.1 1 FBXL17 DGV, D
A4A1 7q32.3 Del 130,223,711–130,389,769 166.1 0 - DGV, D, R
A4A1 15q22.2 Del 58,443,176–58,758,812 308.0 3 ANXA2, NARG2, RORA DGV
A4A1 18p11.2 Dup 7,972,838–8,146,688 143.0 1 PTPRM DGV, D
A5E1 1q44 Dup 244,302,000–247,181,852 2879.9 9 SMYD3, NLRP3, others DGV, D, R
A5E1 3q13.31 Del 117,512,606–118,793,995 1350.2 1 LSAMP DGV, D, R
A5E1 7q21.11-q31.3 Dup 78,193,775–110,468,830 32,275.1 198 MCM7, VGF, others DGV, D, R
A5E1 12p13.33 Del 18,892–1,350,007 1331.1 11 HSN2, RAD52, others DGV, D, R
A5E1 13q31.3 Del 93,268,807–93,537,593 168.7 1 GPC6 D
A5E1 17q24.1 Del 60,106,480–60,543,998 437.5 2 FLJ34306, GNA13 DGV, D
A5E1 20p12.1 Del 14,356,420–14,637,615 281.2 0 - D
A5E1 Xq21.33 Del 96,331,475–96,693,752 362.3 1 DIAPH2 DGV
A5E1 Xq21.33 Dup 96,700,002–97,012,625 312.6 1 DIAPH2 DGV, R
a CNVs and CNCs found in the database of genomic variants (DGV), DECIPHER (D), and RedonCNV2 in Ensembl (R).the boundaries of the deletion, not near the breakpoints,
suggesting a lack of involvement of homologous recombi-
nation in the formation of these CNCs.
Discussion
We have demonstrated that perturbing normal DNA repli-
cation with low-dose aphidicolin results in the induction
of submicroscopic deletions and duplications, or CNCs,
ranging in size from 25 kilobases to several megabases
across the genome in normal human cells. These CNCs
closely resemble many normal human CNVs and de
novo, pathogenic CNCs found in humans and arising in
cancer cells. Sequence from breakpoint junctions of ten
deletions and two duplications showed that most have
short microhomology at the breakpoints with two
showing short insertions and one having no homology.
None had sequence features that would suggest unequal
homologous recombination between sister chromatids as
a mechanism for their formation. These sequence data
strongly suggest that the APH-induced CNCs were gener-
ated by NHEJ or MMEJ mechanisms or replication errors,
which have also been implicated in the formation of
normal CNVs and CNCs in humans and cancer cells.344 The American Journal of Human Genetics 84, 339–350, March 1Despite our previous ﬁndings from mouse-human chro-
mosome 3 hybrids, in which APH-induced deletions were
found at a high frequency at the FRA3B fragile site,26 there
was no clear association of APH-induced CNC breakpoints
in normal ﬁbroblasts with the location of the most
frequently broken common fragile sites. In these earlier
experiments with chr. 3 hybrid cells, there was no selective
disadvantage to cells with deletions at FRA3B or elsewhere
on chromosome 3. However, normal ﬁbroblasts with dele-
tions in fragile site-associated genes may be at a selective
disadvantage. Alternatively, examination of a greater
number of cell clones, longer treatment times, or higher
doses of APH could reveal a trend of CNCs at common
fragile sites.
Analysis of the CNC breakpoints and ﬂanking regions
with a number of algorithms designed to detect repeated
sequences or the potential to form unusual secondary
DNA structures did not reveal any features that might
suggest why replication fork stalling might preferentially
occur at these sites leading toaCNC.However, thedetection
of overlappingCNCs raises thepossibility that some regions
of the genome are predisposed to form CNCs after replica-
tion stress, at least in ﬁbroblasts. None of the APH-induced
CNCbreakpoints precisely coincidedwith those of reported3, 2009
CNVsorCNCsassociatedwithgenetic disorders. This obser-
vation might be due to the relatively low resolution with
which many CNV and disease-associated CNC breakpoints
were mapped. Alternatively, different selective pressures in
cultured ﬁbroblasts and whole organisms could result in
different patterns of copy number alterations.
Figure 3. CNCs Identified in APH-Treated Human Fibroblast Clones
CNCs are mapped onto chromosome ideograms. Red bars to the left of a chromosome indicate deletions. Blue bars to the right of a chro-
mosome indicate duplications.
Figure 4. Mapping of CNCs that Coloc-
alize within the Same Chromosomal
Bands or with Bands Containing Common
Fragile Sites
(A) Deletions (red bars) and duplications
(blue bars) from chr. 3 hybrid clones and
human fibroblast clones mapping to the
same chromosomal bands. Asterisks (*)
indicate CNCs whose breakpoints were
sequenced.
(B) Examples of deletions (red bars) from
human fibroblast clones mapping to chro-
mosomal bands containing common fragile
sites (black bars). Asterisks indicate CNCs
whose breakpoints were sequenced.The American Journal of Human Genetics 84, 339–350, March 13, 2009 345
Figure 5. PCR Strategy for Amplifying and Sequencing Deletion and Duplication Breakpoints
Arrows represent PCR primers, designated P1 and P2, designed to flank deletion (A) and duplication (B) breakpoint junctions. Primers are
designed to amplify breakpoints of duplications in any orientation.The mechanisms leading to the generation of constitu-
tional CNVs and CNCs in humans and those arising in
cancer cells have been inferred based on the sequences at
deletion and duplication breakpoints. It is apparent from
such analyses that more than one mechanism is respon-
sible. Meiotic NAHR between repeat sequences is clearly
the underlying cause of a signiﬁcant class of CNVs and
most, if not all, recurrent CNCs associated with genetic
and developmental abnormalities. However, it is also clear
that the majority of normal CNVs and nonrecurrent CNCs
in cancer cells do not have breakpoint junction sequences
consistent with this mechanism. Rather, the junction
sequences implicate NHEJ, alternative end-joining mecha-346 The American Journal of Human Genetics 84, 339–350, Marchnisms such as MMEJ, or a form of replication-associated,
long-range template switching in their formation. For
example, by using a long-range paired-end sequencing
approach, Korbel et al.19 analyzed the sequences at more
than 200 CNVsmore than 3 kb in size. Most were predicted
to have originated from NHEJ (56%) in which breakpoint
junctions were ﬂanked by <5 bp of microhomology. This
was prevalent even among larger CNVs (>20 kb) and in
regions that contained large segmental duplications near,
but not at, the breakpoints.19 By using a similar
sequencing approach, Campbell et al.24 have reported
that 62% of acquired deletions and tandem duplications
in two lung cancer cell lines had microhomologies at theTable 3. Deletion Breakpoint Sequences from APH-Treated Clones
Clone Location Size Breakpoint 1 Breakpoint 2
p-43a 3p24.3 162,051 bp .CTTAATGGGGCCAaaggagacctctg. .tttcatgtctccaCAGGTGTTGATCT.
851a 3p14.2 35,750 bp .TCTTTAAAAGATGTCttaaagtaata. .tgacatatattTGTCAACATATGCCT.
3-16a 3q26.3 91,035 bp .CAGTGGCACAATCTCggctcactgca. .gtataaccctgTCTCAAAAAAAAAAA.
A1B1 17p13.1 265,205 bp .TCTTGTTAATAACAaggctattggct. .tgccaagatgccCACAAATCGAGAAC.
A3A2 3q13.31 762,148 bp .ACTTAGGATAATAGcctccagctaca. .tcttatagggcaAGGATCATAGCTAC.
A3A2 11p15 88,497 bp .ACTGCCTCCATATcgtgagttgctag. .aggaggcagacagGTTCCTGGCATAA.
A3A2 15q23 30,620 bp .TTGCTATTTTCTGGgttgtttttttt. .ttaatccattcaGCCACTCTATGTCT.
A3A2 18p11.23 233,818 bp .AGTGTCCAGT(GTCCTA)tgaatgaatt. .tcagcttattattCTTTGAATAAAGT.
A4A1 7q32 168,106 bp .CTTCTCAACATTCCTggtcaagacag. .gctgatcactcTCCTCTTTAAGCACT.
a Chr. 3 hybrid clones.26
Underline indicates microhomology; lowercase indicates deletion; parentheses indicate insertion.13, 2009
Table 4. Duplication Breakpoints in APH-Treated Clones
Clone Location Size Orientation Breakpoint 1 Breakpoint 2
A3A2 10q25 2,432,875 bp Head-Tail .AAGAAATATATGGTgaattgattt. .tctacgcctgTGGTAACCACCAAT.
A4A1 5q21.3 228,040 bp Head-Tail .CTTTCCCAGACT(AAATG)gattttttaaat. .taaaatggaataCTATTTAGCAAT.
Underline indicates microhomology; lowercase indicates duplication; parentheses indicate insertion.breakpoints, which were also attributed to NHEJ mecha-
nisms. NHEJ has been predicted as the mechanism
involved in producing DMD (MIM 300377) deletions and
duplications in some cases of Duchene muscular
dystrophy (DMD [MIM 310200]),33,34 deletions of the
PLP1 (MIM 300401) gene in patients with Pelizaeus-Merz-
bacher disease (PMD [MIM 312080]),35,36 and atypical
deletions in some cases of some the Smith-Magenis
syndrome (SMS [MIM 182290]) deletion22 and 16p11.2
duplications in autism (MIM 209850).14
Lee et al.23 have provided the most detailed evidence of
the involvement of aberrant replication mechanisms in
producing duplications. This group analyzed the break-
point junctions in 17 Pelizaeus-Merzbacher disease
patients with nonrecurrent duplications of the PLP1
gene. They found evidence for NHEJ with short microho-
mologies at the junctions in some of the duplications,
whereas others were complex and interrupted with normal
sequences and also showed microhomologies at break-
points. A model termed ‘‘fork stalling and template switch-
ing’’ (FoSTeS) was proposed to account for these ﬁndings,
based on a long-range template switching mechanism
proposed by Slack et al.37 from studies in E. coli. In this
mechanism, stalled or collapsed replication forks switch
to another active fork to bypass the DNA lesion. ForksThe Ameencountering low-copy repeats or areas that are difﬁcult
to replicate are proposed to be prone to stalling and occa-
sionally switch templates in the presence of a nearby
template at another fork, thus generating chromosomal
rearrangements. This process might require regions of
microhomology for the switch to occur and long-range
switching could be inﬂuenced by the genomic architecture
and formation of complex secondary structures in the
regions. A related replication-based repair mechanism has
recently been proposed to function in the generation of
large segmental duplications (SDs) in yeast associated
with altered replication origin ﬁring and replication fork
progression.38 These SDs were generated through a
proposed mechanism of long-range template switching
between microsatellites or microhomologies that requires
the pol32 subunit of DNA polymerase delta. This mecha-
nism, named microhomology/microsatellite-induced rep-
lication (MMIR), differs from other DNA double-strand
break repair pathways, as MMIR-mediated duplications
still occur in the combined absence of homologous recom-
bination, microhomology-mediated, and nonhomologous
end-joining machineries.
The breakpoint junction sequences of the APH-induced
CNCs reported here also mainly show short microhomolo-
gies, suggesting a common mechanism with many humanFigure 6. Example of a Complex Deletion at 3q26.31 Detected in Chr. 3 Hybrid Clone 6-30
The red line indicates a deletion predicted by SegMNT at a 5000 bp interval average. Arrows indicate the positions of PCR assays used to
detect the presence (þ) or absence () of human chromosome 3 sequences in the clone. Blue areas represent undeleted regions, and pink
areas represent deleted regions.rican Journal of Human Genetics 84, 339–350, March 13, 2009 347
CNVs and CNCs and stress-induced duplications in E. coli
and yeast. APH directly inhibits DNA polymerase function
and can lead to stalled replication forks39,40 and activation
of multiple latent replication origins in regions of slowed
replication.41 These direct effects on DNA replication
support a mechanism involving replication errors and
replication-based repair mechanisms such as FoSTeS/
MMIR in generating APH-induced CNCs. In all previous
reports, long-range template switching models have been
used to explain duplications. It is reasonable to predict
that such long-range template switching could also lead
to deletions. Our ﬁnding of a number of interrupted dele-
tions further suggests that a form of template switching at
stalled forks could lead to some of our observed CNCs,
given that the FosSTeS model was used to explain interrup-
ted duplications in the PLP1 gene.23
Alternatively, deletions and perhaps duplications could
be produced via nonhomologous end-joining mecha-
nisms. Whereas studies of CNVs and disease-associated
CNCs have implicated classic NHEJ mechanisms, the
related but less well understood MMEJ mechanism is
equally likely to be involved in their generation and APH-
induced CNCs. This mechanism is independent of the
core NHEJ factors, including DNA-PK, ligase IV, Ku70/80
heterodimer, and XRCC4.42–44 MMEJ is also independent
of the RAD51 (mammalian cells) and Rad52 (S. cerevisiae)
proteins that are central to homologous recombination
repair.45 For either NHEJ or MMEJ to process a DNA break,
the broken ends must be in close proximity to each other.
Many CNCs observed after APH treatment are hundreds
of kb in size; it is not clear how joining of these distantly
separated ends could proceed. However, a possible mecha-
nism is suggested from recent reports of the repair of
distant breaks in telomere sequences46 and during immu-
noglobulin gene recombination47 showing that 53BP1 is
a facilitator of NHEJ at distant DNA ends, perhaps acting
by increasing the mobility of the local chromatin to facili-
tate synapsis and processing of ends.
NHEJ appears to be downregulated during mammalian
meiosis25 and chromosome replication is not taking place
in meiotic cells. Therefore, the involvement of FoSTeS/
MMIR or NHEJ mechanisms in producing a subset of
CNVs and CNCs associated with congenital disorders
suggests a mitotic rather than meiotic cell origin, perhaps
in the mammalian germline where DNA is actively repli-
cating. A mitotic cell origin has previously been proposed
for some PLP1 and DMD duplications in humans,33–36
and recent data from studies of variation in CNVs inmono-
zygotic twins48 and mouse ES cells49 support a somatic cell
origin for some CNVs. This has a number of implications.
For example, males complete mitotic divisions leading to
mature germ cells during adulthood whereas females
complete these divisions during fetal development with
arrest of oocytes in MI. Thus, males would be at risk for
generatingnewCNCs in sperm throughadulthoodwhereas
females would be at risk during fetal development. As
a result, fetal exposure to agents that perturb replication348 The American Journal of Human Genetics 84, 339–350, March 1may be a factor in producing CNCs in maternal grandchil-
dren. Alternatively, MMEJ or other alternative end-joining
pathways could be active at some point during meiosis to
produce these lesions.
This report represents the ﬁrst direct experimental
evidence that replication stress can lead to submicroscopic
copy number changes across the genome in normal
human cells. Whether these effects are speciﬁc for APH
or can be extrapolated to other forms of replication stress
is currently unknown, but our results suggest that CNCs
are a frequent consequence of replication stress in mitotic
cells, a major cause of endogenous DNA damage that can
be inﬂuenced by exogenous agents and growth conditions.
These ﬁndings have potential broad implications for
congenital and genetic disorders, cancer, and evolution.
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